Roflumilast 31722-0623-32

Package NDC

31722-0623-32

Manufacturer: Camber Pharmaceuticals, Inc.
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: October 15, 2022
Listing Expires: December 31, 2026
Application: ANDA208213

Need to source Roflumilast? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Roflumilast	500 ug/1

Drug Class

Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]

Selected Package

31722-0623-32Selected

100 BLISTER PACK in 1 CARTON (31722-623-32) / 10 TABLET in 1 BLISTER PACK (31722-623-31)

Other packages for this product(2)

31722-0623-30

30 TABLET in 1 BOTTLE (31722-623-30)

View →

31722-0623-90

90 TABLET in 1 BOTTLE (31722-623-90)

View →